Wed.Jul 07, 2021

article thumbnail

A well-funded cancer drug startup brings on GSK's Axel Hoos as CEO

Bio Pharma Dive

Hoos, who led cancer R&D at GSK, will take over as head of Scorpion Therapeutics, a new biotech company that's raised $270 million in venture funding since launching last October.

Drugs 344
article thumbnail

Jardiance becomes first SGLT2 inhibitor to show benefit in HFpEF

Pharma Times

Eli Lilly and Boehringer Ingelheim have revealed positive results from a Phase III study of Jardiance in HFpEF patients

158
158
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Moderna puts seasonal flu vaccine ambitions to the test

Bio Pharma Dive

Having proved mRNA's might in COVID-19, the biotech company aims to develop similar vaccines for other respiratory illnesses caused by influenza, RSV and metapneumovirus.

article thumbnail

Veterinary Drug for COVID-19 Patients? Studies Present Confusing Case

BioSpace

Ivermectin has become a contentious issue as to whether it effectively prevents and treats COVID-19. Several studies suggest it is effective, while others have indicated it is not.

Drugs 105
article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

WHO backs Roche, Sanofi drugs for COVID-19 after research ups and downs

Bio Pharma Dive

Once long-shot experiments in the rush to repurpose drugs for COVID-19, both Actemra and Kevzara could become more widely used, renewing questions around cost and access.

Drugs 269
article thumbnail

WHO endorses IL-6 receptor blockers for COVID-19, Roche engaging with agency on guideline implications

BioPharma Reporter

WHO is recommending the use of interleukin-6 (IL)-6 receptor blockers in patients with severe and critical COVID-19, adding them to its list of treatments for the virus.

More Trending

article thumbnail

Agenus Sets Sights on New California Site Near Genentech

BioSpace

Agenus, an immuno-oncology company based out of Lexington, Mass., has purchased a 120-acre plot of land near Genentech’s manufacturing facility in Vacaville, Cali.

article thumbnail

New patent for Optinose Us drug XHANCE

Drug Patent Watch

Annual Drug Patent Expirations for XHANCE Xhance is a drug marketed by Optinose Us Inc and is included in one NDA. There are thirteen patents protecting this drug. XHANCE drug…. The post New patent for Optinose Us drug XHANCE appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 98
article thumbnail

Here’s What’s Happening for World Chocolate Day

XTalks

World Chocolate Day is a day dedicated to celebrating chocolate each year on July 7. This day was chosen because some believe that the same day in the year 1550 was the date that chocolate was first introduced in Europe. This day brings together all the chocolate lovers around to world to indulge and feel no guilt eating their favorite treats. There is a wide range of chocolate to choose from in the market —including milk chocolate, white chocolate and dark chocolate — but within these broad cat

article thumbnail

New patent expiration for Astellas drug MYCAMINE

Drug Patent Watch

Annual Drug Patent Expirations for MYCAMINE Mycamine is a drug marketed by Astellas and is included in one NDA. It is available from one supplier. There is one patent protecting…. The post New patent expiration for Astellas drug MYCAMINE appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 98
article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

FDA rejects Provention’s type 1 diabetes drug teplizumab

pharmaphorum

The FDA indicated something was not well with Provention Bio’s filing for type 1 diabetes therapy teplizumab in April when it delayed its review. Now, the agency has rejected the application entirely, sending the company’s shares into a steep slide. The complete response letter (CRL) for teplizumab as a treatment to delay clinical type 1 diabetes in at-risk individuals reiterates the FDA’s concerns around the pharmacokinetics (PK) data for the antibody.

Drugs 98
article thumbnail

University of Maryland researchers record brainwaves to measure ‘cybersickness’

Scienmag

In a first-of-its-kind study, the UMD team used electroencephalography (EEG) to better understand and work toward solutions for VR-induced discomfort Credit: Maryland Blended Reality Center If a virtual world has ever left you feeling nauseous or disorientated, you’re familiar with cybersickness, and you’re hardly alone. The intensity of virtual reality (VR)–whether that’s standing on the […].

article thumbnail

Another hurdle down as EU clears AstraZeneca’s Alexion takeover

pharmaphorum

The European Commission has given competition clearance to the $39 billion acquisition of Alexion by AstraZeneca, leaving the UK as the last remaining obstacle to getting the deal across the line. The EU approval comes after the merger has already been okayed by the US, Japan and a number of other countries around the world, and AZ says it is now hoping to completing the transaction by the end of this quarter.

Sales 98
article thumbnail

Scientists use artificial intelligence to detect gravitational waves

Scienmag

Credit: (Image by Argonne Leadership Computing Facility, Visualization and Data Analytics Group [Janet Knowles, Joseph Insley, Victor Mateevitsi, Silvio Rizzi].) When gravitational waves were first detected in 2015 by the advanced Laser Interferometer Gravitational-Wave Observatory (LIGO), they sent a ripple through the scientific community, as they confirmed another of Einstein’s theories and marked the birth […].

article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

Imugene Cancer Vaccine Displays Promise in Gastric Tumors, Mid-Stage Data Shows

BioSpace

A Phase II study shows the vaccine by Imugene Limited improved survival rates and overall response in patients with HER2-positive stomach or gastroesophageal junction cancer.

article thumbnail

Better gripping with intelligent picking robots

Scienmag

Researchers from Germany and Canada work on new AI methods for picking robots Credit: Amadeus Bramsiepe, KIT Production, warehouse, shipping – where goods are produced, stored, sorted or packed, picking also takes place. This means that several individual goods are removed from storage units such as boxes or cartons and reassembled. Researchers at the Karlsruhe […].

article thumbnail

Biogen Updates Prescribing Label of Controversial Alzheimer’s Drug

BioSpace

The saga continues for Biogen’s Alzheimer’s drug Aduhelm as the U.S. Food and Drug Administration approved an updated label that emphasizes the disease stages for which the drug was approved.

Drugs 98
article thumbnail

Diversification in supply chain crucial to avoid ‘food shock’ in cities

Scienmag

Credit: Michael Gomez, Penn State Diversification in the sourcing of food into cities can go a long way to tempering “food shock” — a sudden drop in food supply due to unforeseen events, according to a team of researchers from Penn State and Northern Arizona University, who developed a statistical risk model linking supply chain […].

article thumbnail

The New Age of Decentralized Clinical Trials

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

article thumbnail

The Great Resignation: 3 Tips You Need to Know to Keep Your Best Employees

BioSpace

“The Great Resignation” is a term that’s been coined to describe the wave of people leaving their jobs for other opportunities or exiting the workforce altogether.

103
103
article thumbnail

Researchers detail the most ancient bat fossil ever discovered in Asia

Scienmag

Credit: Matthew Jones LAWRENCE — A new paper appearing in Biology Letters describes the oldest-known fragmentary bat fossils from Asia, pushing back the evolutionary record for bats on that continent to the dawn of the Eocene and boosting the possibility that the bat family’s “mysterious” origins someday might be traced to Asia.

article thumbnail

JHL Execs Indicted for Theft of Genentech Trade Secrets

BioSpace

The two were charged with conspiracy to commit trade secret theft and wire fraud, international money laundering and obstruction of justice.

98
article thumbnail

‘Fortunate accident’ may yield immunity weapon against antibiotic-resistant bacteria

Scienmag

Johns Hopkins Medicine study uncovers enzyme inhibitor that boosts immune system to fight MRSA and other dangerous skin infections Credit: National Institute of Allergy and Infectious Diseases, National Institutes of Health FOR IMMEDIATE RELEASE In what turned out to be one of the most important accidents of all time, Scottish bacteriologist Alexander Fleming returned to […].

article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

Gov’t sets out ten-year strategy for the UK’s life sciences sector

Pharma Times

New 'Life Sciences Vision' outlines seven critical healthcare missions

article thumbnail

New study helps explain ‘silent earthquakes’ along New Zealand’s North Island

Scienmag

Seamounts offer clue to solving a tectonic puzzle Credit: Christine Chesley, using GeoMapApp and data from William Ryan et al., Geochemistry, Geophysics, Geosystems (2009) The Hikurangi Margin, located off the east coast of the North Island of New Zealand, is where the Pacific tectonic plate dives underneath the Australian tectonic plate, in what scientists call […].

article thumbnail

New CEOs Named at Two Biopharma Companies

BioSpace

Scorpion Therapeutics announced its new CEO Dr. Axel Hoos while Tenax Therapeutics named Christopher Giordano as its new chief executive.

98
article thumbnail

EHR alerts go unread, do not lead to deprescribing of medicines linked to dementia

Scienmag

Credit: Regenstrief Institute INDIANAPOLIS — The vast majority of electronic health record (EHR) alerts attempting to reduce the prescribing of high-risk medications linked to dementia in older adults went unread in a study led by research scientists from Regenstrief Institute, Purdue University and Indiana University School of Medicine. The goal of the intervention was to […].

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Is Ocugen and Bharat Biotech’s COVID-19 Vaccine Too Little, Too Late?

BioSpace

The vaccine demonstrated efficacy in mild, moderate, and severe COVID-19 of 77.8% with efficacy against severe disease of 93.4%.

article thumbnail

For many students, double-dose algebra leads to college attainment

Scienmag

Credit: Saint Louis University ST. LOUIS — In the United States, low-income and minority students are completing college at low rates compared to higher-income and majority peers — a detriment to reducing economic inequality. Double-dose algebra could be a solution, according to a new study published in roceedings of the National Academy of Sciences of […].

91
article thumbnail

Draper Achieves First SARS-CoV-2 Virus Replication in a Lung-on-a-Chip Platform

BioSpace

For the first time in an organ-on-a-chip model, the live SARS-CoV-2 virus has successfully infected and replicated in human tissue.

103
103
article thumbnail

5 million deaths a year caused by global climate related abnormal temps

Scienmag

More than five million deaths a year can be attributed to abnormal hot and cold temperatures Credit: Monash University More than five million extra deaths a year can be attributed to abnormal hot and cold temperatures, according to a world first international study led by Monash University. The study found deaths related to hot temperatures […].

article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.